Related Experiment Video
Updated: Feb 14, 2026

Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay
Published on: March 1, 2011
Neuromodulation in Inflammatory Skin Disease.
Eric J Yang1,2, Sahil Sekhon3, Kristen M Beck3
1Department of Dermatology, University of California-San Francisco, San Francisco, CA, USA. ericjyang@outlook.com.
Vagus nerve stimulation shows promise for treating inflammatory skin conditions. This neuromodulation technique reduces inflammation, similar to biologics, offering new hope for severe skin disease.
Area of Science:
- Dermatology
- Immunology
- Neurology
Background:
- Severe inflammatory skin diseases lack effective treatments.
- Vagus nerve stimulation (VNS) reduces inflammation in rheumatoid arthritis and inflammatory bowel disease.
- Cytokine profiles in VNS studies resemble those from biologic therapies used in dermatology.
Purpose of the Study:
- To explore the efficacy of neuromodulation in inflammatory diseases.
- To assess the potential translation of VNS findings to dermatology for treating inflammatory skin conditions.
Main Methods:
- Review of existing literature on vagus nerve stimulation in inflammatory conditions.
- Analysis of cytokine profile changes in response to VNS.
- Comparison of VNS mechanisms with those of biologic therapies in inflammatory skin disease.
Main Results:
- Vagus nerve stimulation demonstrates anti-inflammatory effects.
- Observed cytokine changes suggest shared pathways between VNS and biologics.
- Evidence supports the potential application of neuromodulation in dermatology.
Conclusions:
- Neuromodulation, specifically vagus nerve stimulation, presents a potential novel therapeutic strategy for inflammatory skin diseases.
- The anti-inflammatory mechanisms of VNS align with those targeted by current dermatological treatments, suggesting a promising therapeutic avenue.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

